Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila

Nature Communications

Volumn 3, Issue , 2012, Pages

  Lee, Seongsoo ^a   Wang, Ji Wu ^a   Yu, Wendou ^a   Lu, Bingwei ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; PAR 1 PROTEIN; PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

DISEASE INCIDENCE; DISEASE TREATMENT; ENZYME ACTIVITY; FLY; NEUROLOGY; PHYSIOLOGY; PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DROSOPHILA; F BOX MOTIF; NERVE CELL PLASTICITY; NEUROMUSCULAR SYNAPSE; NONHUMAN; POSTSYNAPTIC INHIBITION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

EID: 84871759268     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2278     Document Type: Article

References (50)

1. Guo, S. & Kemphues, K. J. Par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81, 611-620 (1995).
2. Matenia, D. & Mandelkow, E. M. The tau of MARK: a polarized view of the cytoskeleton. Trends Biochem. Sci. 34, 332-342 (2009).
3. Hurov, J. & Piwnica-Worms, H. The Par-1/MARK family of protein kinases: from polarity to metabolism. Cell Cycle 6, 1966-1969 (2007). (Pubitemid 47327882)
4. Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E. M. & Mandelkow, E. MARK, a novel family of protein kinases that phosphorylate microtubule- associated proteins and trigger microtubule disruption. Cell 89, 297-308 (1997). (Pubitemid 27199901)
5. Trinczek, B., Brajenovic, M., Ebneth, A. & Drewes, G. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. J. Biol. Chem. 279, 5915-5923 (2004). (Pubitemid 38220624)
6. Nishimura, I., Yang, Y. & Lu, B. PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116, 671-682 (2004). (Pubitemid 38326726)
7. Lee, V. M., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159 (2001). (Pubitemid 32695256)
8. Timm, T. et al. MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J. 22, 5090-5101 (2003). (Pubitemid 37222029)
9. Lizcano, J. M. et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23, 833-843 (2004). (Pubitemid 38418750)
10. Wang, J. W., Imai, Y. & Lu, B. Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. J. Neurosci. 27, 574-581 (2007). (Pubitemid 46143761)
11. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998). (Pubitemid 28411135)
12. Schwartz, A. L. & Ciechanover, A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 49, 73-96 (2009).
13. Jiang, J. Regulation of Hh/Gli signaling by dual ubiquitin pathways. Cell Cycle 5, 2457-2463 (2006). (Pubitemid 44785822)
14. Jiang, J. & Struhl, G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 391, 493-496 (1998). (Pubitemid 28086550)
15. Winston, J. T. et al. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and betacatenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 13, 270-283 (1999). (Pubitemid 29095799)
16. Ho, M. S., Ou, C., Chan, Y. R., Chien, C. T. & Pi, H. The utility F-box for protein destruction. Cell Mol. Life Sci. 65, 1977-2000 (2008).
17. Nijman, S. M. et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786 (2005). (Pubitemid 41721026)
18. DiAntonio, A. et al. Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 412, 449-452 (2001).
19. Holtzman, D. M., Morris, J. C. & Goate, A. M. Alzheimer's disease: the challenge of the second century. Sci. Transl. Med. 3, 77sr71 (2011).
20. Xue, L. et al. Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila. Dev. Cell 13, 446-454 (2007). (Pubitemid 47308678)
21. Zhang, Y. et al. PAR-1 kinase phosphorylates Dlg and regulates its postsynaptic targeting at the Drosophila neuromuscular junction. Neuron 53, 201-215 (2007). (Pubitemid 46074401)
22. Brajenovic, M., Joberty, G., Kuster, B., Bouwmeester, T. & Drewes, G. Comprehensive proteomic analysis of human par protein complexes reveals an interconnected protein network. J. Biol. Chem. 279, 12804-12811 (2004). (Pubitemid 38445853)
23. Al-Hakim, A. K. et al. Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains. Biochem. J. 411, 249-260 (2008). (Pubitemid 351580177)
24. Chen, X., Zhang, B. & Fischer, J. A. A specific protein substrate for a deubiquitinating enzyme: liquid facets is the substrate of fat facets. Genes Dev. 16, 289-294 (2002). (Pubitemid 34111408)
25. Mortimer, N. T. & Moberg, K. H. The Drosophila F-box protein Archipelago controls levels of the trachealess transcription factor in the embryonic tracheal system. Dev. Biol. 312, 560-571 (2007). (Pubitemid 350183981)
26. Iijima, K., Gatt, A. & Iijima-Ando, K. Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Hum. Mol. Genet. 19, 2947-2957 (2010).
27. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112 (2007). (Pubitemid 46432529)
28. Ittner, L. M. & Gotz, J. Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65-72 (2011).
29. Ittner, L. M. et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397 (2010).
30. Hoover, B. R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067-1081 (2010).
31. Heidary, G. & Fortini, M. E. Identification and characterization of the Drosophila tau homolog. Mech. Dev. 108, 171-178 (2001). (Pubitemid 32923065)
32. Lee, S., Liu, H. P., Lin, W. Y., Guo, H. & Lu, B. LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction. J. Neurosci. 30, 16959-16969 (2010).
33. DiAntonio, A. & Hicke, L. Ubiquitin-dependent regulation of the synapse. Annu. Rev. Neurosci. 27, 223-246 (2004). (Pubitemid 39050403)
34. Yi, J. J. & Ehlers, M. D. Emerging roles for ubiquitin and protein degradation in neuronal function. Pharmacol. Rev. 59, 14-39 (2007). (Pubitemid 46333994)
35. Selkoe, D. J. Alzheimer's disease is a synaptic failure. Science 298, 789-791 (2002). (Pubitemid 35231524)
36. Xu, J., Taya, S., Kaibuchi, K. & Arnold, A. P. Spatially and temporally specific expression in mouse hippocampus of Usp9x, a ubiquitin-specific protease involved in synaptic development. J. Neurosci. Res. 80, 47-55 (2005). (Pubitemid 40577292)
37. Xu, J. Age-related changes in Usp9x protein expression and DNA methylation in mouse brain. Brain Res. Mol. Brain Res. 140, 17-24 (2005). (Pubitemid 41446143)
38. Chin, J. Y. et al. Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study. J. Neuropathol. Exp. Neurol. 59, 966-971 (2000).
39. Yu, W. et al. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Abeta on synapses and dendritic spines. Hum. Mol. Genet. 21, 1384-1390 (2011).
40. Augustinack, J. C., Schneider, A., Mandelkow, E. M. & Hyman, B. T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. (Berl) 103, 26-35 (2002). (Pubitemid 36075309)
41. Perez, M. et al. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience 130, 339-347 (2005). (Pubitemid 40125472)
42. Zempel, H., Thies, E., Mandelkow, E. & Mandelkow, E. M. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 11938-11950 (2010).
43. Gylys, K. H. et al. Synaptic changes in Alzheimer's disease: increased amyloidbeta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am. J. Pathol. 165, 1809-1817 (2004). (Pubitemid 39435178)
44. Almeida, C. G. et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20, 187-198 (2005). (Pubitemid 41476246)
45. Seshadri, S. et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303, 1832-1840 (2010).
46. Kim, E. & Sheng, M. PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5, 771-781 (2004). (Pubitemid 39336214)
47. Lee, F. K. et al. The role of ubiquitin linkages on alpha-synuclein inducedtoxicity in a Drosophila model of Parkinson's disease. J. Neurochem. 110, 208-219 (2009).
48. Grima, B. et al. The F-box protein slimb controls the levels of clock proteins period and timeless. Nature 420, 178-182 (2002). (Pubitemid 35340121)
49. Martin, St S. G. & Johnston, D. A role for Drosophila LKB1 in anteriorposterior axis formation and epithelial polarity. Nature 421, 379-384 (2003). (Pubitemid 36157936)
50. Ko, H. W., Jiang, J. & Edery, I. Role for Slimb in the degradation of Drosophila period protein phosphorylated by doubletime. Nature 420, 673-678 (2002). (Pubitemid 36764499)